PriceTargets.com logo

Community Health Systems - CYH Stock Price Target and Predictions

  • Consensus Rating: Reduce
  • Consensus Price Target: $3.28
  • Forecasted Upside: 10.36%
  • Number of Analysts: 8
  • Breakdown:
  • 2 Sell Ratings
  • 5 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$2.98 As of 05/1/2026 04:59 PM ET
▲ +0.135 (4.75%)

This chart shows the closing price for CYH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Community Health Systems Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CYH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CYH

Analyst Price Target is $3.28
▲ +10.36% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Community Health Systems in the last 3 months. The average price target is $3.28, with a high forecast of $5.00 and a low forecast of $2.00. The average price target represents a 10.36% upside from the last price of $2.98.

This chart shows the closing price for CYH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Reduce

The current consensus among 8 investment analysts is to reduce stock in Community Health Systems. This rating changed within the last month from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
11/9/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
2/7/2025
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 2 sell ratings
Ratings as of
5/8/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 2 sell ratings
Ratings as of
8/6/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 3 sell ratings
Ratings as of
11/4/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 6 hold ratings
  • 1 sell ratings
Ratings as of
2/2/2026
  • 1 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 2 sell ratings
Ratings as of
4/3/2026
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 2 sell ratings
Ratings as of
5/3/2026

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/24/2026Weiss RatingsDowngradeSell (D+) ➝ Sell (D)
4/24/2026Zacks ResearchDowngradeStrong-Buy ➝ Hold
4/23/2026Truist FinancialLower TargetHold ➝ Hold$3.50 ➝ $3.00
4/23/2026BarclaysLower TargetEqual Weight ➝ Equal Weight$3.50 ➝ $3.00
4/13/2026Truist FinancialLower TargetHold ➝ Hold$4.00 ➝ $3.50
3/19/2026Weiss RatingsDowngradeHold (C-) ➝ Sell (D+)
2/23/2026Zacks ResearchUpgradeHold ➝ Strong-Buy
2/20/2026UBS GroupBoost TargetNeutral ➝ Neutral$3.60 ➝ $3.70
1/7/2026Wells Fargo & CompanyLower TargetUnderweight ➝ Underweight$3.00 ➝ $2.00
1/5/2026Truist FinancialSet Target$4.50
12/29/2025Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
12/22/2025Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
12/15/2025Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
12/8/2025Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
11/25/2025Weiss RatingsReiterated RatingHold (C-) ➝ Hold (C-)
11/19/2025Weiss RatingsReiterated RatingHold (C-) ➝ Hold (C-)
11/13/2025Weiss RatingsReiterated RatingHold (C-) ➝ Hold (C-)
11/7/2025Weiss RatingsUpgradeSell (D-) ➝ Hold (C-)
10/27/2025UBS GroupBoost TargetNeutral ➝ Neutral$3.20 ➝ $3.60
10/8/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
10/7/2025Wells Fargo & CompanyBoost TargetUnderweight ➝ Underweight$2.50 ➝ $3.00
9/27/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
8/14/2025Wells Fargo & CompanyLower TargetUnderweight ➝ Underweight$3.50 ➝ $2.50
7/25/2025UBS GroupLower TargetNeutral ➝ Neutral$3.50 ➝ $3.20
7/25/2025Royal Bank Of CanadaLower TargetOutperform ➝ Outperform$6.00 ➝ $5.00
7/24/2025BarclaysLower TargetEqual Weight ➝ Equal Weight$4.00 ➝ $3.50
7/24/2025Jefferies Financial GroupReiterated RatingBuy ➝ Hold$4.25 ➝ $3.00
7/16/2025Truist FinancialBoost TargetHold ➝ Hold$3.50 ➝ $4.25
5/29/2025Wells Fargo & CompanyReiterated RatingUnderweight ➝ Underweight$2.00 ➝ $3.50
4/25/2025UBS GroupSet Target$3.50
4/11/2025Truist FinancialLower TargetHold ➝ Hold$4.00 ➝ $3.00
4/9/2025GuggenheimInitiated CoverageNeutral
3/10/2025Wells Fargo & CompanyLower TargetUnderweight ➝ Underweight$2.50 ➝ $2.00
2/20/2025UBS GroupLower TargetNeutral ➝ Neutral$4.80 ➝ $4.10
2/20/2025BarclaysLower TargetEqual Weight ➝ Equal Weight$5.00 ➝ $4.00
1/6/2025Truist FinancialLower TargetHold ➝ Hold$5.00 ➝ $3.50
11/25/2024Wells Fargo & CompanyDowngradeEqual Weight ➝ Underweight$5.00 ➝ $2.50
11/22/2024Raymond James FinancialDowngradeMarket Perform ➝ Underperform
10/25/2024Truist FinancialLower TargetHold ➝ Hold$5.50 ➝ $5.00
10/24/2024BarclaysBoost TargetEqual Weight ➝ Equal Weight$3.00 ➝ $5.00
8/14/2024UBS GroupBoost TargetNeutral ➝ Neutral$4.70 ➝ $5.10
8/12/2024Royal Bank Of CanadaReiterated RatingOutperform ➝ Outperform$6.00 ➝ $6.00
7/30/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$3.50 ➝ $5.00
7/25/2024OppenheimerBoost TargetOutperform ➝ Outperform$4.50 ➝ $5.00
7/15/2024Truist FinancialBoost TargetHold ➝ Hold$3.75 ➝ $4.25
4/26/2024Truist FinancialBoost TargetHold ➝ Hold$3.25 ➝ $3.75
4/25/2024OppenheimerLower TargetOutperform ➝ Outperform$5.50 ➝ $4.50
3/6/2024BarclaysInitiated CoverageEqual Weight$3.00
2/22/2024OppenheimerLower TargetOutperform ➝ Outperform$6.50 ➝ $5.50
10/30/2023Royal Bank Of CanadaLower TargetOutperform ➝ Outperform$7.00 ➝ $6.00
10/20/2023Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$5.00 ➝ $3.00
10/11/2023Truist FinancialLower TargetHold ➝ Hold$5.00 ➝ $3.50
8/7/2023OppenheimerReiterated RatingOutperform ➝ Outperform$6.50
6/20/2023Truist FinancialBoost Target$4.50 ➝ $5.00
5/3/2023Royal Bank Of CanadaLower Target$11.00 ➝ $7.00
2/17/2023Truist FinancialBoost Target$4.75 ➝ $8.00
2/17/2023Credit Suisse GroupBoost TargetNeutral$3.30 ➝ $8.50
1/19/2023OppenheimerBoost TargetOutperform$5.00 ➝ $5.50
1/3/2023Wells Fargo & CompanyBoost TargetEqual Weight$3.00 ➝ $4.50
11/23/2022Credit Suisse GroupLower TargetNeutral$4.00 ➝ $3.30
11/1/2022OppenheimerLower Target$5.00
10/13/2022Credit Suisse GroupLower Target$4.00
9/6/2022Credit Suisse GroupLower Target$5.00
8/9/2022Credit Suisse GroupLower Target$6.50
8/4/2022CitigroupLower Target$14.00 ➝ $6.00
8/1/2022Credit Suisse GroupLower TargetNeutral$8.00 ➝ $6.50
7/19/2022Credit Suisse GroupSet Target$8.00
6/16/2022Loop CapitalInitiated CoverageHold$5.00
6/15/2022Bank of AmericaDowngradeBuy ➝ Neutral$7.50 ➝ $5.50
6/3/2022Credit Suisse GroupLower Target$10.50
4/29/2022CitigroupLower Target$18.00 ➝ $14.00
3/28/2022Wells Fargo & CompanyInitiated CoverageEqual Weight$12.00
12/13/2021Bank of AmericaUpgradeUnderperform ➝ Buy$14.00 ➝ $16.00
10/29/2021Credit Suisse GroupBoost TargetNeutral$12.00 ➝ $14.50
10/13/2021Truist FinancialLower TargetHold$14.00 ➝ $12.00
9/23/2021UBS GroupInitiated CoverageNeutral$12.50
8/23/2021Truist FinancialLower TargetHold$17.00 ➝ $14.00
8/3/2021BarclaysBoost TargetUnderweight$6.00 ➝ $10.00
7/30/2021Credit Suisse GroupBoost TargetNeutral$10.00 ➝ $12.00
6/18/2021Jefferies Financial GroupReiterated RatingBuy
6/10/2021Royal Bank Of CanadaUpgradeSector Perform ➝ Outperform$12.00 ➝ $21.00
5/5/2021Jefferies Financial GroupUpgradeHold ➝ Buy$11.00 ➝ $18.00
(Data available from 5/3/2021 forward)

News Sentiment Rating

0.02 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 6 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2025
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/3/2026
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/2/2026
  • 2 very positive mentions
  • 11 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
3/4/2026
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/3/2026
  • 3 very positive mentions
  • 12 positive mentions
  • 5 negative mentions
  • 1 very negative mentions
Mentions as of
5/3/2026

Current Sentiment

  • 3 very positive mentions
  • 12 positive mentions
  • 5 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Community Health Systems logo
Community Health Systems, Inc. owns, leases, and operates general acute care hospitals in the United States. It offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. The company also provides outpatient services at primary care practices, urgent care centers, free-standing emergency departments, ambulatory surgery centers, imaging and diagnostic centers, and direct-to-consumer virtual health visits. The company was incorporated in 1996 and is headquartered in Franklin, Tennessee.
Read More

Today's Range

Now: $2.98
Low: $2.80
High: $3.00

50 Day Range

MA: $3.12
Low: $2.49
High: $3.66

52 Week Range

Now: $2.98
Low: $2.38
High: $4.47

Volume

1,416,176 shs

Average Volume

1,964,485 shs

Market Capitalization

$419.24 million

P/E Ratio

0.87

Dividend Yield

N/A

Beta

1.89

Frequently Asked Questions

What sell-side analysts currently cover shares of Community Health Systems?

The following Wall Street sell-side analysts have issued research reports on Community Health Systems in the last year: Barclays PLC, Jefferies Financial Group Inc., Royal Bank Of Canada, Truist Financial Corporation, UBS Group AG, Wall Street Zen, Weiss Ratings, Wells Fargo & Company, and Zacks Research.
View the latest analyst ratings for CYH.

What is the current price target for Community Health Systems?

0 Wall Street analysts have set twelve-month price targets for Community Health Systems in the last year. Their average twelve-month price target is $3.28, suggesting a possible upside of 10.4%. Royal Bank Of Canada has the highest price target set, predicting CYH will reach $5.00 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $2.00 for Community Health Systems in the next year.
View the latest price targets for CYH.

What is the current consensus analyst rating for Community Health Systems?

Community Health Systems currently has 2 sell ratings, 5 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Reduce."
View the latest ratings for CYH.

What other companies compete with Community Health Systems?

Other companies that are similar to Community Health Systems include Acadia Healthcare, HCA Healthcare, U.S. Physical Therapy, Petco Health and Wellness and Alcon. Learn More about companies similar to Community Health Systems.

How do I contact Community Health Systems' investor relations team?

Community Health Systems' physical mailing address is 4000 MERIDIAN BOULEVARD, FRANKLIN TN, 37067. The company's listed phone number is (615) 465-7000 and its investor relations email address is [email protected]. The official website for Community Health Systems is www.chs.net. Learn More about contacing Community Health Systems investor relations.